HOME >> MEDICINE >> NEWS
Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer

Neo-adjuvant (pre-operative) chemotherapy does not improve survival chances of patients with resectable non-small cell lung cancer compared with surgery alone. The findings are reported early Online and in an upcoming edition of The Lancet, timed to coincide with presentation of the paper at the American Society of Clinical Oncology meeting in Chicago.

And an accompanying comment says that surgery should not be delayed through using neo-adjuvant chemotherapy; it recommends that chemotherapy should take place after surgery (adjuvant chemotherapy).

Richard Stephens, Medical Research Council Clinical Trials Unit, London, UK and colleagues studied 519 patients from 70 centres in the UK, Netherlands, Germany and Belgium.

Most patients were clinical stage I (61%), with 31% stage II and 7% stage III. The researchers found that although nearly half (49%) of the patients responded well to neo-adjuvant chemotherapy and 31% experienced downgrades in their clinical staging, there was no benefit in terms of overall survival.

The authors say however, that the hazard ratios (relative safety) of neo-adjuvant versus adjuvant therapy are similar, and that the different techniques could be used to target different subgroups of patients.

They say: Neo-adjuvant chemotherapy might best be used when tumours need down-staging pre-operatively, or where existing comorbities could make recovery from surgery slower and so delay the optimum administration of [post-operative] chemotherapy.

Combining the result of this trial with previous trials suggests use of neo-adjuvant chemotherapy results in a relative increase survival benefit of 12% and an absolute survival benefit of 5% at five years.

The authors conclude: Although there was no evidence of a difference in overall survival with neo-adjuvant chemotherapy, the result is statistically consistent with previous trials, and therefore adds considerable weight to the curre
'"/>

Contact: Richard Stephens
rs@ctu.mrc.ac.uk
44-781-574-4104
Lancet
2-Jun-2007


Page: 1 2

Related medicine news :

1. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
2. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
3. Brain-boosting pill alleviates post-chemotherapy fogginess
4. Most pediatric chemotherapy mistakes reach patients
5. Growth factors given with chemotherapy associated with increased risk of blood diseases
6. Clear guidelines on oral chemotherapy needed
7. Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
8. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
9. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
10. Order of chemotherapy, radiation has no effect on breast cancer survival
11. St. Jude finds clues to hearing loss from chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... ... (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) to develop a ... patients who have undergone open heart surgery. , The AGH/CMU team was recently ...
(Date:8/31/2020)... ... 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical distributor Gulf ... responders across the United States. Since the start of the global COVID-19 pandemic, ... medical centers , hospitals , firefighters , and public schools ...
(Date:8/31/2020)... Colo. (PRWEB) , ... August 31, 2020 , ... ... provider of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – ... Responder Psychology . , Among the first of its kind in the ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , ... in a state of panic, experiencing deep anxiety, immense stress, and right now are needing ... timely when most people on the planet are experiencing a great degree of emotional discomfort, ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, ... with advanced heart failure, today announced that the company has been awarded a ... from the National Heart, Lung, and Blood Institute of the National Institutes of ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... SEATTLE (PRWEB) , ... August 31, 2020 , ... ... technology research and advisory guide, has named Cloudticity a Gold winner in the ... are industry and peer recogniti o ns from Network Products Guide ...
(Date:8/27/2020)... , ... August 27, 2020 , ... ... software, today announced the successful completion of their 2020 System and Organizational Controls ... their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect their long-standing ...
(Date:8/27/2020)... ... 2020 , ... Trella Health, the leading source of provider ... CRM, marketing automation, and contact center solutions for senior living communities and post-acute ... performance intelligence data and insights into Enquire’s CRM solution to serve as a ...
Breaking Medicine Technology:
Cached News: